Showing results (451-460 of 477) with videos related to
Sort By:
Pageof 48
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 2, 2014
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitorsA D Kirk, A Guasch, H Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphomaU Vitolo, S Cortellazzo, A M Liberati, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2017
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft FunctionA B Adams, J Goldstein, C Garrett, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantationN A Turgeon, J G Avila, J A Cano, et al.Frontiers in Cardiovascular Medicine|December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, ItalyS V Benatti, S Venturelli, G Crotti, et al.The Journal of Experimental Medicine|July 7, 1997
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responsesW W Shuford, K Klussman, D D Tritchler, et al.Pageof 48